Filana Therapeutics, Inc.
FLNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069530
In the last 90 days, Filana Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 85 institutions reported holding it in 13F filings for Q2 2026, worth $15.1M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Filana Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +7 vs. Q2 2025
- Shares held
- 13.8M
- +1.54M (+12.6%) vs. Q2 2025
- Total value
- $40.1M
- +$17.9M (+81.0%) vs. Q2 2025
- New holders
- 20
- 20 more added
- Sold out
- 13
- 33 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FLNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 85 | $15.1M |
| Q1 2026 | 101 | $23.1M |
| Q4 2025 | 107 | $27.3M |
| Q3 2025 | 103 | $40.1M |
| Q2 2025 | 97 | $22.1M |
| Q1 2025 | 117 | $23.6M |
| Q4 2024 | 137 | $41.1M |
| Q3 2024 | 161 | $412.5M |
| Q2 2024 | 145 | $164.6M |
| Q1 2024 | 142 | $235.3M |
| Q4 2023 | 153 | $313.5M |
| Q3 2023 | 141 | $215.4M |
| Q2 2023 | 152 | $286.8M |
| Q1 2023 | 145 | $287.9M |
| Q4 2022 | 153 | $332.5M |
| Q3 2022 | 174 | $438.9M |
| Q2 2022 | 149 | $279.2M |
| Q1 2022 | 163 | $390.2M |
| Q4 2021 | 171 | $504.1M |
| Q3 2021 | 181 | $757.3M |
| Q2 2021 | 169 | $893.4M |
| Q1 2021 | 128 | $458.2M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Filana Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,409,156 | $4.10M | 0.00% | −136,751−8.8% | Reduced |
| Marshall Wace, LLP | 2,061,286 | $6.00M | 0.01% | +1,989,572+2,774.3% | Added |
| Vanguard Group Inc | 2,289,523 | $6.66M | 0.00% | +119,451+5.5% | Added |
| HRT Financial LP | 0 | $0 | 0.00% | −94,855−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −46,842−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −35,868−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −29,782−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −27,351−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −16,985−100.0% | Sold out |
| Aristides Capital LLC | 0 | $0 | 0.00% | −16,092−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −12,355−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −11,587−100.0% | Sold out |
| Empirical Asset Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −1,647−100.0% | Sold out |
| Mount Yale Investment Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Legacy Investment Solutions, LLC | – | – | – | – | Not filed |